Accueil   Diary - News   All news Novadiscovery announces new collaboration with Takeda

Novadiscovery announces new collaboration with Takeda

 

 

Novadiscovery (“NOVA”), a leading health tech company offering JINKO, a best-in-class clinical trial simulation platform to predict drug efficacy and optimize clinical trial development, today announces that it has entered into a new collaboration with Takeda Pharmaceutical Company Limited (“Takeda”) aimed at incorporating clinical simulation technology on virtual patients into Takeda France’s access strategy. This agreement builds on an existing relationship between the companies that began in 2017.

 

 

Regulatory agencies are increasingly advocating for the expanded use of in silico technology to improve clinical trial efficiency and increase the probability of regulatory success. Takeda, through its association with NOVA, is leading the way in incorporating disease modelling and trial simulation in virtual populations in its pipeline development programs.

 

 

Read the press release